gD

The company previously reported encouraging data showing that its Vaxfectin (R)-formulated monovalent prophylactic vaccine (encoding HSV-2 glycoprotein D, or gD) protected mice against challenge with 50 times a lethal dose (LD50) of HSV-2, provided sterilizing immunity and inhibited viral counts at both primary and latent infection sites.

unknown title 2011

EYFP-PML I fusion under the control of the weak gD promoter by the modified HSV-1 virus vECFP-ICP4, whose immediate early protein ICP4 has been coupled with ECFP.

WN.com - Articles related to Scientists uncover mysterious workings of cholera bacteria 2010

Time course of infection of human fibroblasts expressing an EYFP-PML I fusion under the control of the weak gD promoter by the modified

WN.com - Articles related to Scientists uncover mysterious workings of cholera bacteria 2010

Time course of infection of human fibroblasts expressing an EYFP-PML I fusion under the control of the weak gD promoter by the modified HSV-1 virus vECFP-ICP4, whose immediate early protein ICP4 has been coupled with ECFP.

WN.com - Articles related to Scientists uncover mysterious workings of cholera bacteria 2010

A Vaxfectin (R)-formulated trivalent therapeutic version of the vaccine (encoding gD plus the HSV-2 tegument proteins UL46 and UL47) significantly reduced (p

unknown title 2011

Ë'ÓH'ée#~: ðaÅNEèϘ£ ¦ gD XíÕšàQ † w¶u-Lš_¥˜íÃs Ž×n'k} EL¯ ‹ OwÓr³jD7 ‰ þëTÌåBKÙS † ÒvÒl [Ÿ0¹ iÀ+} ¯nÊ@ "L˜°ø×m. ù¶ C$µ

Tokyo Toshokan 2008

Ë'ÓH'ée#~: ðaÅNEèϘ£ ¦ gD XíÕšàQ † w¶u-Lš_¥˜íÃs Ž×n'k} EL¯ ‹ OwÓr³jD7 ‰ þëTÌåBKÙS † ÒvÒl [Ÿ0¹ iÀ+} ¯nÊ@ "L˜°ø×m. ù¶ C$µ

Tokyo Toshokan 2008